Literature DB >> 18356162

Phosphorylation of MDMX mediated by Akt leads to stabilization and induces 14-3-3 binding.

Vanessa Lopez-Pajares1, Mihee M Kim, Zhi-Min Yuan.   

Abstract

The critical tumor suppressor p53 is mutated or functionally inactivated in nearly all cancers. We have shown previously that the MDM2-MDMX complex functions as an integral unit in targeting p53 for degradation. Here we identify the small protein 14-3-3 as a binding partner of MDMX, which binds at the C terminus (Ser367) in a phosphorylation-dependent manner. Importantly, we demonstrate that the serine/threonine kinase Akt mediates phosphorylation of MDMX at Ser367. This phosphorylation leads to stabilization of MDMX and consequent stabilization of MDM2. Previous studies have shown that Akt phosphorylates and stabilizes MDM2. Our data suggest that stabilization of MDMX by Akt may be an alternative mechanism by which Akt up-regulates MDM2 protein levels and exerts its oncogenic effects on p53 in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18356162      PMCID: PMC2376244          DOI: 10.1074/jbc.M710030200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Identification of a sequence element from p53 that signals for Mdm2-targeted degradation.

Authors:  J Gu; D Chen; J Rosenblum; R M Rubin; Z M Yuan
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

3.  HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.

Authors:  B P Zhou; Y Liao; W Xia; Y Zou; B Spohn; M C Hung
Journal:  Nat Cell Biol       Date:  2001-11       Impact factor: 28.824

4.  MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.

Authors:  Francesca Gentiletti; Francesca Mancini; Marco D'Angelo; Ada Sacchi; Alfredo Pontecorvi; Aart G Jochemsen; Fabiola Moretti
Journal:  Oncogene       Date:  2002-01-31       Impact factor: 9.867

Review 5.  How do 14-3-3 proteins work?-- Gatekeeper phosphorylation and the molecular anvil hypothesis.

Authors:  Michael B Yaffe
Journal:  FEBS Lett       Date:  2002-02-20       Impact factor: 4.124

6.  Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.

Authors:  J Parant; A Chavez-Reyes; N A Little; W Yan; V Reinke; A G Jochemsen; G Lozano
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

7.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Authors:  L D Mayo; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis.

Authors:  Tanya M Gottlieb; Juan Fernando Martinez Leal; Rony Seger; Yoichi Taya; Moshe Oren
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

9.  Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53.

Authors:  Y F Ramos; R Stad; J Attema; L T Peltenburg; A J van der Eb; A G Jochemsen
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

10.  p53-dependent inhibition of FKHRL1 in response to DNA damage through protein kinase SGK1.

Authors:  Han You; YingJu Jang; Annick Itie You-Ten; Hitoshi Okada; Jennifer Liepa; Andrew Wakeham; Kathrin Zaugg; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

View more
  35 in total

Review 1.  [EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].

Authors:  T Longerich
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

Review 2.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

3.  Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms.

Authors:  Jie Lu; John S Kovach; Francis Johnson; Jeffrey Chiang; Richard Hodes; Russell Lonser; Zhengping Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

4.  p53 protects against LPS-induced lung endothelial barrier dysfunction.

Authors:  Nektarios Barabutis; Christiana Dimitropoulou; Charalampos Birmpas; Atul Joshi; Gagan Thangjam; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-02-20       Impact factor: 5.464

5.  AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.

Authors:  Anna de Polo; Zhongling Luo; Casimiro Gerarduzzi; Xiang Chen; John B Little; Zhi-Min Yuan
Journal:  J Mol Cell Biol       Date:  2017-04-01       Impact factor: 6.216

6.  EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.

Authors:  Rossella Pellegrino; Diego F Calvisi; Olaf Neumann; Venkatesh Kolluru; Josephine Wesely; Xin Chen; Chunmei Wang; Torsten Wuestefeld; Sara Ladu; Nahla Elgohary; Justo Lorenzo Bermejo; Bernhard Radlwimmer; Martin Zörnig; Lars Zender; Frank Dombrowski; Matthias Evert; Peter Schirmacher; Thomas Longerich
Journal:  Hepatology       Date:  2014-03-27       Impact factor: 17.425

7.  The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding.

Authors:  James P Madigan; Feng Hou; Linlei Ye; Jicheng Hu; Aiping Dong; Wolfram Tempel; Marielle E Yohe; Paul A Randazzo; Lisa M Miller Jenkins; Michael M Gottesman; Yufeng Tong
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

8.  Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage.

Authors:  Samuel García; Myriam Liz; Juan J Gómez-Reino; Carmen Conde
Journal:  Arthritis Res Ther       Date:  2010-02-26       Impact factor: 5.156

9.  Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases.

Authors:  Yunyuan V Wang; Mathias Leblanc; Mark Wade; Aart G Jochemsen; Geoffrey M Wahl
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743

10.  MDM4 (MDMX) and its Transcript Variants.

Authors:  F Mancini; G Di Conza; F Moretti
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.